Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Melanoma × propranolol CR × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 3 Propranolol 2 talimogene laherparepvec 1 sargramostim 1 romiplostim 1 propranolol CR 1 imisopasem manganese 1 dabrafenib 1 cobimetinib 1 aldesleukin 1 Vemurafenib 1 Paclitaxel 1 ON 01910 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Interleukin-2 1 CA-4948 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03384836 2025-07-02

Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery

Roswell Park Cancer Institute

Phase 1/2 Suspended

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡